Telangana's Ambitious Life Sciences Vision for 2030 Unveiled at Global Forum
Telangana Sets Its Sights on Global Life Sciences Leadership
At the World Economic Forum 2026 held in Davos, Switzerland, the Telangana government has officially rolled out its ambitious Next-Gen Life Sciences Policy for 2026-30. The new policy aims to position Telangana among the top five life sciences hubs worldwide by the year 2030, with an investment target of USD 25 billion. This strategic framework reflects a significant pivot from conventional manufacturing towards an emphasis on innovation, advanced therapeutic solutions, and sustainable biomanufacturing processes.
A Transformative Approach to Life Sciences
The heart of Telangana's new policy is its focus on creating a value-driven ecosystem that integrates research and development, advanced manufacturing, and global market participation. By targeting the establishment of 500,000 high-quality jobs and a more profound integration into the global life sciences value chain, Telangana is reshaping its identity within this fast-evolving industry.
The policy was introduced by Chief Minister Mr. A. Revanth Reddy and marks a pivotal moment for the state. The vision incorporates elements such as precision fermentation, advanced cellular and gene therapies, and cutting-edge manufacturing methods, supported by a robust infrastructure to facilitate this growth.
Mr. Reddy emphasized, “We are building one of the world's most trusted and transformational biosciences ecosystems—driving global health impact from Telangana. The unveiling of this policy at Davos underscores our belief in cross-border collaborations and shared innovation as the keys to our future.” This underscores the administration’s commitment to redefining Telangana's role in the life sciences arena, shifting from a supply chain participant to a global creator of therapies and health solutions.
Developing the Life Sciences Infrastructure
Central to implementing this new policy will be the establishment of world-class facilities, including the Green Pharma City and ten Pharma Villages, alongside the expansion of Genome Valley. These initiatives promise to create an environment conducive to both local and international businesses, fostering advanced research and high-quality production. Furthermore, the launch of a Life Sciences Innovation Fund aims to stimulate an influx of new investments into deep-tech ventures and the burgeoning life sciences sector.
In tandem with physical infrastructure, Telangana’s government is also investing in human capital through education and research-focused initiatives. The newly established Telangana School of Life Sciences is set to become a premier institution nurturing future talent in life sciences, ensuring that India can sustain a competitive advantage in this crucial sector.
Strengthening Global Collaborations
The Next-Gen Life Sciences Policy is backed by confidence from multiple global entities, including major pharmaceutical companies like Amgen, Sanofi, and Bristol Myers Squibb, which have either established or enhanced their research and development centers in Hyderabad. This trend reflects a growing recognition of Telangana's potential, showcasing its readiness to host global health research initiatives and a commitment to solving pressing healthcare challenges.
As Telangana advances its goals, it is also keenly aware of the global context. It plays a vital role in addressing issues such as vaccine supply—a field in which the region notably provides one-third of the global demand. The strategic focus on high-value research activities will bolster its capacity to respond to worldwide health challenges, particularly in times of crises such as pandemics.
Conclusion
Telangana's Next-Gen Life Sciences Policy, with its groundbreaking vision for the coming years, places the state at the forefront of a sector that is integral not just to local, but global health outcomes. The comprehensive strategy aims to bridge gaps in healthcare delivery, strengthen resilience in supply chains, and emerge as a nucleus of innovation that not only supports the region but also fosters global health advancements. The ambitious roadmap laid out today promises not only to elevate Telangana’s standing in the life sciences field but also to drive significant global health impact through collaboration and innovation. With a focus on sustainability, value creation, and innovation, Telangana is set to redefine its narrative in the global life sciences landscape.